Literature DB >> 126557

Biological properties of the peptidoglycan.

B Heymer.   

Abstract

This review deals with those biological activities of peptidoglycan that are not directly analogous to the properties of gram-negative bacterial endotoxin. The report is divided into 3 major parts: 1. A survey of peptidoglycan activities such as the induction of inflammatory skin reactions, lesion-enhancing activity (virulence factor), inhibition of phagocytosis of bacteria, inhibition of cell migration, cytotoxicity to mammalian cells, potentiation of the humoral and cellular immune response (adjuvant activity) and enhancement of tumor defense in experimental animals. 2. A presentation of factors which may influence these biological activities of peptidoglycan. 3. A brief discussion of the potential mechanisms of action of peptidoglycan.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126557

Source DB:  PubMed          Journal:  Z Immunitatsforsch Exp Klin Immunol        ISSN: 0300-872X


  12 in total

Review 1.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Mitogenic activity of staphylococcal peptidoglycan.

Authors:  R Dziarski; A Dziarski
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Soluble peptidoglycan from Staphylococcus aureus is a murine B-lymphocyte mitogen.

Authors:  U M Babu; A R Zeiger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

4.  Lysis and biodegradation of microorganisms in infectious sites may involve cooperation between leukocyte, serum factors and bacterial wall autolysins: a working hypothesis.

Authors:  I Ginsburg; M Lahav
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

5.  Modulation of mitogenic responsiveness by staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Detection of soluble peptidoglycan in urine after penicillin administration.

Authors:  H Park; A R Zeiger; H R Schumacher
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Complement consumption gonococcal peptidoglycan.

Authors:  B H Petersen; R S Rosenthal
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions.

Authors:  M R Gold; C L Miller; R I Mishell
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

9.  Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus.

Authors:  A R Zeiger; C U Tuazon; J N Sheagren
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  Changes of pharmacokinetics of trimethoprim after pretreatment with streptococcal peptidoglycan.

Authors:  J Lavický; J Cerný; L Celeda; J Rotta; J Kvĕtina; H Raśková; A Kubícek
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.